O'Brien Patrick

Insider·ARROWHEAD PHARMACEUTICALS, INC.·ARWR·Insider since 2025·Form 4 filings: 15
Trades YTD
12
Trades (12m)
12
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

12 transactions
05 Jan 2026
SOLD
$ARWR
46
$68.00
S
05 Jan 2026
SOLD
$ARWR
2,336
$64.04
S
05 Jan 2026
SOLD
$ARWR
5,873
$62.91
S
05 Jan 2026
SOLD
$ARWR
900
$62.25
S
05 Jan 2026
SOLD
$ARWR
600
$61.12
S
05 Jan 2026
SOLD
$ARWR
313
$68.00
S
05 Jan 2026
SOLD
$ARWR
900
$66.01
S
05 Jan 2026
SOLD
$ARWR
2,700
$64.44
S
05 Jan 2026
SOLD
$ARWR
11,842
$63.84
S
05 Jan 2026
SOLD
$ARWR
13,451
$62.96
S
05 Jan 2026
SOLD
$ARWR
6,164
$62.23
S
05 Jan 2026
SOLD
$ARWR
4,368
$61.20
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · ARROWHEAD PHARMACEUTICALS, INC.

last 30 days

No active insider cluster at ARROWHEAD PHARMACEUTICALS, INC. in the last 30 days. Patrick's recent transactions appear in the section above.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event Patrick is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 10:30 UTC.